Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
399 Leser
Artikel bewerten:
(2)

Botannis Labs, Inc. Receives Cannabinoids and Terpenes Testing Permit From NYS Office of Cannabis Management

The permit allows the testing of cannabinoids and terpenes in addition to filth/foreign materials, metals, moisture content, and mycotoxins

HAUPPAUGE, NY / ACCESSWIRE / July 12, 2023 / Botannis Labs, Inc., a leading provider of analytical testing services for the nutraceutical and pharmaceutical industries, is pleased to announce that the Hauppauge, Long Island-based testing laboratory received approval for testing of cannabinoids and terpenes last month from the New York State Office of Cannabis Management (OCM). As only one of 15 permitted testing laboratories in New York State and the only laboratory in Suffolk County, Botannis is permitted to test for cannabinoids and terpenes including delta-10 THC, filth/foreign material, heavy metals, moisture content, mycotoxins/aflatoxins.

Botannis Labs, Inc, Wednesday, July 12, 2023, Press release picture

Terpenes are a class of natural compounds consisting of unsaturated hydrocarbons that are found in the essential oils of plants. They determine the smell of many plants and herbs and are found abundantly in the cannabis plant. Cannabinoids are compounds that are also found in the cannabis plant. Terpenes, along with cannabinoids like THC and CBD, may contribute to the entourage effect - a synergy derived from the natural combination of these compounds.

With this updated permit from the OCM, Botannis can now test cannabis products for potency as levels may change from plant to plant based on various factors such as climate, soil type, and age of the crop. Botannis can test for and determine exact potency levels in finished cannabis products for consumer safety and quality assurance.

"We're very happy to add onto our cannabis testing capabilities," said Matt Wolf, CEO of Botannis Labs, Inc. "Our permit from the OCM allows us to carry out cannabis potency testing to measure the cannabinoids present and the strength of these compounds. Cannabis product consumers deserve to know what is in the products they are purchasing, and cannabis manufacturers deserve to have reliable testing laboratories that can assess potency levels."

"With terpenes added to our cannabis testing permit, Botannis can analyze terpenes in medical and adult use cannabis," said Jeff Reingold, COO of Botannis Labs, Inc. "Terpene analysis allows us to provide a more comprehensive scope of product testing for manufacturers and consumers that trust us to tell them exactly what is in the product that they are selling and consuming."

Learn more about testing protocols and standards and find the full list of permitted laboratories on the NY OCM's website.

For more information about Botannis Labs and its services, please visit www.botannis.com.

ABOUT BOTANNIS LABS, INC.

Botannis is a NY State Licensed, ISO-Certified, cGMP product testing lab that provides a comprehensive scope of harmonized GMP testing services and regulatory consulting. Botannis Labs' team of experts leverage their decades of experience to utilize optimized testing methods and quality procedures to help assure the compliance of partner brands and the safety of consumers. With modern capabilities and a rigorous dedication to quality, Botannis provides clients access to advanced analysis and cutting-edge laboratory services. Learn more at www.botannis.com.

Contact Information

Mathew Chamakkala
Vice President, Quality Control
info@botannis.com

SOURCE: Botannis Labs, Inc.

.

View source version on accesswire.com:
https://www.accesswire.com/767389/Botannis-Labs-Inc-Receives-Cannabinoids-and-Terpenes-Testing-Permit-From-NYS-Office-of-Cannabis-Management

© 2023 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.